A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight

NCT06440980 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

533

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Obese
Overweight
Obesity

Interventions

DRUG: Orforglipron

Sponsor

Eli Lilly and Company